Stereotactic Radiation Therapy for Prostate Cancer: A Breakthrough in Treatment
2 months, 1 week ago

Stereotactic Radiation Therapy for Prostate Cancer: A Breakthrough in Treatment

The Hindu  

A new study compared two groups of patients with early prostate cancer with a median age of 69.8 years. Half (433 participants) received five sessions of stereotactic radiation therapy, the other half (431 participants) received standard radiation therapy consisting of at least 20 sessions. The researchers found no long-term difference in outcomes between the groups, with 95% of patients showing no evidence of disease five years after treatment. These cure rates are equivalent to patients who had their prostates surgically removed.

Melbourne Law Technology Cancer Medicine  does  patients  disease  compare  prostate  radiation  stereotactic  treatments  treatment  therapy  radiotherapy  cancer

History of this topic

Shorter duration of radiation safe in treating prostate cancer: Study
5 years, 11 months ago

Shorter duration of radiation safe in treating prostate cancer: Study

India TV News  

Men with low or intermediate-risk prostate cancer can safely undergo higher doses of radiation over a significantly shorter period of time and still have the same, successful outcomes as from a much longer course of treatment, according to researchers including one of Indian-origin. "Most men with low or intermediate-risk prostate cancer undergo conventional radiation, which requires them to come in …

Discover Related